Skip to main content

Table 1 General characteristics of the patients with and without LV thrombus formation

From: Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy

Variable

No (n=85)

Yes (n=15)

p-value

Age (years)

57(50,64)

63(50,69)

0.18

Female

15(18%)

1(7%)

0.49

Current smoker

37(44%)

7(47%)

0.20

Hypertension

27(32%)

7(47%)

0.41

Hyperlipidemia

39(46%)

9(60%)

0.47

Diabetes mellitus

6(7%)

2(13%)

0.76

Previous myocardial infarction

4(5%)

0(0%)

0.89

Weight (kg)

84.0(74.5,92.5)

80(77.0,92.0)

0.99

Systolic blood pressure (mmHg)

130(120,144)

135(130,150)

0.33

Peak CK (ugr/L)

2197(1236,4182)

6128(4556,8061)

<0.01

Infarct size (% of LAD area by SPECT)

63.8(40.5,76.8)

82.5(71.3,93.1)

<0.01

  1. Hypertension is defined as antihypertensive treatment or measured blood pressure above 140/90 mmHg. Hyperlipidemia is defined as baseline fasting total cholesterol above 5.5 mmol/L or previous use of cholesterol lowering medication. P-values refer to differences between the LV thrombus group and those without thrombus formation. CK; creatine kinase, LAD; the left anterior descending artery, SPECT; single photon emission computer tomography.